Mad Money' host Jim Cramer looks at several healthcare stocks and shares his perspective on their trajectory in 2025.

Merck Chairman and CEO Robert Davis joins 'Mad Money' host Jim Cramer at the JPMorgan Healthcare Conference to talk recent ...

We recently published an article titled Jim Cramer Discussed These 21 Stocks As Bond Yields Soared. In this article, we are ...

We recently published an article titled Jim Cramer Discussed These 21 Stocks As Bond Yields Soared. In this article, we are ...

CNBC’s Jim Cramer stresses the importance of investing for the long term, highlighting healthcare stocks Eli Lilly, Merck and Regeneron.

Mad Money” host Jim Cramer rings the lightning round bell, which means he’s giving his answers to callers’ stock questions at ...

For this article, we compiled a list of 12 stocks that were discussed by Jim Cramer during the episode of Mad Money on ...

We recently published an article titled Jim Cramer Discussed These 21 Stocks As Bond Yields Soared. In this article, we are ...

Merck CEO Rob Davis told CNBC’s Jim Cramer that there’s more to the pharmaceutical giant than its lucrative cancer drug, ...

Honeywell International is considering splitting into two companies. Jim Cramer is bullish on the company's plans to break up ...

The Consumer Financial Protection Bureau is suing Capital One for 'cheating' customers out of $2 billion in interest.

Bitcoin combines currency, technology, and value storage, offering limitless potential for the future of transactions.